These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 15044951)

  • 1. Regulatory regions and critical residues of NOD2 involved in muramyl dipeptide recognition.
    Tanabe T; Chamaillard M; Ogura Y; Zhu L; Qiu S; Masumoto J; Ghosh P; Moran A; Predergast MM; Tromp G; Williams CJ; Inohara N; Núñez G
    EMBO J; 2004 Apr; 23(7):1587-97. PubMed ID: 15044951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of IL-8 and IL-1beta expression in Crohn's disease associated NOD2/CARD15 mutations.
    Li J; Moran T; Swanson E; Julian C; Harris J; Bonen DK; Hedl M; Nicolae DL; Abraham C; Cho JH
    Hum Mol Genet; 2004 Aug; 13(16):1715-25. PubMed ID: 15198989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbial induction of CARD15 expression in intestinal epithelial cells via toll-like receptor 5 triggers an antibacterial response loop.
    Begue B; Dumant C; Bambou JC; Beaulieu JF; Chamaillard M; Hugot JP; Goulet O; Schmitz J; Philpott DJ; Cerf-Bensussan N; Ruemmele FM
    J Cell Physiol; 2006 Nov; 209(2):241-52. PubMed ID: 16897777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane recruitment of NOD2 in intestinal epithelial cells is essential for nuclear factor-{kappa}B activation in muramyl dipeptide recognition.
    Barnich N; Aguirre JE; Reinecker HC; Xavier R; Podolsky DK
    J Cell Biol; 2005 Jul; 170(1):21-6. PubMed ID: 15998797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease.
    Inohara N; Ogura Y; Fontalba A; Gutierrez O; Pons F; Crespo J; Fukase K; Inamura S; Kusumoto S; Hashimoto M; Foster SJ; Moran AP; Fernandez-Luna JL; Nuñez G
    J Biol Chem; 2003 Feb; 278(8):5509-12. PubMed ID: 12514169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural insights into the MDP binding and CARD-CARD interaction in zebrafish (Danio rerio) NOD2: a molecular dynamics approach.
    Maharana J; Patra MC; De BC; Sahoo BR; Behera BK; De S; Pradhan SK
    J Mol Recognit; 2014 May; 27(5):260-75. PubMed ID: 24700593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. hPepT1 selectively transports muramyl dipeptide but not Nod1-activating muramyl peptides.
    Ismair MG; Vavricka SR; Kullak-Ublick GA; Fried M; Mengin-Lecreulx D; Girardin SE
    Can J Physiol Pharmacol; 2006 Dec; 84(12):1313-9. PubMed ID: 17487240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational studies on receptor-ligand interactions between novel buffalo (Bubalus bubalis) nucleotide-binding oligomerization domain-containing protein 2 (NOD2) variants and muramyl dipeptide (MDP).
    Brahma B; Patra MC; Mishra P; De BC; Kumar S; Maharana J; Vats A; Ahlawat S; Datta TK; De S
    J Mol Graph Model; 2016 Apr; 65():15-26. PubMed ID: 26897084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease.
    van Heel DA; Ghosh S; Butler M; Hunt KA; Lundberg AM; Ahmad T; McGovern DP; Onnie C; Negoro K; Goldthorpe S; Foxwell BM; Mathew CG; Forbes A; Jewell DP; Playford RJ
    Lancet; 2005 May 21-27; 365(9473):1794-6. PubMed ID: 15910952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a synthetic muramyl peptide derivative with enhanced Nod2 stimulatory capacity.
    Rubino SJ; Magalhaes JG; Philpott D; Bahr GM; Blanot D; Girardin SE
    Innate Immun; 2013 Oct; 19(5):493-503. PubMed ID: 23339926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human endothelial cells express NOD2/CARD15 and increase IL-6 secretion in response to muramyl dipeptide.
    Davey MP; Martin TM; Planck SR; Lee J; Zamora D; Rosenbaum JT
    Microvasc Res; 2006 Mar; 71(2):103-7. PubMed ID: 16414084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection.
    Girardin SE; Boneca IG; Viala J; Chamaillard M; Labigne A; Thomas G; Philpott DJ; Sansonetti PJ
    J Biol Chem; 2003 Mar; 278(11):8869-72. PubMed ID: 12527755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The frameshift mutation in Nod2 results in unresponsiveness not only to Nod2- but also Nod1-activating peptidoglycan agonists.
    Netea MG; Ferwerda G; de Jong DJ; Werts C; Boneca IG; Jéhanno M; Van Der Meer JW; Mengin-Lecreulx D; Sansonetti PJ; Philpott DJ; Dharancy S; Girardin SE
    J Biol Chem; 2005 Oct; 280(43):35859-67. PubMed ID: 16115863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal responses to specific NOD1-activating peptidoglycan agonists in the presence of the NOD2 frameshift and other mutations in Crohn's disease.
    van Heel DA; Hunt KA; Ghosh S; Hervé M; Playford RJ
    Eur J Immunol; 2006 Jun; 36(6):1629-35. PubMed ID: 16637007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Splicing of NOD2 (CARD15) RNA transcripts.
    Leung E; Hong J; Fraser A; Krissansen GW
    Mol Immunol; 2007 Jan; 44(4):284-94. PubMed ID: 16675018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Recognition of Muramyl Dipeptide Occurs in the Leucine-rich Repeat Domain of Nod2.
    Lauro ML; D'Ambrosio EA; Bahnson BJ; Grimes CL
    ACS Infect Dis; 2017 Apr; 3(4):264-270. PubMed ID: 27748583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing.
    Maeda S; Hsu LC; Liu H; Bankston LA; Iimura M; Kagnoff MF; Eckmann L; Karin M
    Science; 2005 Feb; 307(5710):734-8. PubMed ID: 15692052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NOD2 3020insC mutation and the pathogenesis of Crohn's disease: impaired IL-1beta production points to a loss-of-function phenotype.
    Netea MG; Ferwerda G; de Jong DJ; Girardin SE; Kullberg BJ; van der Meer JW
    Neth J Med; 2005 Sep; 63(8):305-8. PubMed ID: 16186640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogen sensing by nucleotide-binding oligomerization domain-containing protein 2 (NOD2) is mediated by direct binding to muramyl dipeptide and ATP.
    Mo J; Boyle JP; Howard CB; Monie TP; Davis BK; Duncan JA
    J Biol Chem; 2012 Jun; 287(27):23057-67. PubMed ID: 22549783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemically synthesized pathogen-associated molecular patterns increase the expression of peptidoglycan recognition proteins via toll-like receptors, NOD1 and NOD2 in human oral epithelial cells.
    Uehara A; Sugawara Y; Kurata S; Fujimoto Y; Fukase K; Kusumoto S; Satta Y; Sasano T; Sugawara S; Takada H
    Cell Microbiol; 2005 May; 7(5):675-86. PubMed ID: 15839897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.